Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Aimmune starts POSEIDON trial to treat peanut allergy

Aimmune’s AR101 is currently under development for treatment of peanut allergy. Credit: caligula1995.

  • Aimmune Therapeutics

Go Top